GNRH1 and prostate carcinoma: Androgen deprivation therapy (ADT), which can be achieved surgically (by orchidectomy) or chemically using luteinizing hormone-releasing hormone (LHRH) agonists and LHRH antagonists is therefore a cornerstone in the treatment of prostate cancer (Fig. 1).